Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -27.92% | -62.93% |
Apr. 11 | Syncona to Sell Stake in Portfolio Company to Century Therapeutics | MT |
Feb. 20 | Syncona’s Takeover of Freeline Therapeutics Becomes Effective | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter McCormack
DFI | Director of Finance/CFO | 45 | 09-12-31 |
Bruce Jackson
CTO | Chief Tech/Sci/R&D Officer | 55 | 13-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leonardo de Luca
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 149,719,272 | 71,715,197 ( 47.90 %) | 0 | 47.90 % |
Company contact information
1st Jan change | Capi. | |
---|---|---|
-62.93% | 0 | |
+3.53% | 2,990B | |
+3.05% | 83.1B | |
+1.20% | 76.88B | |
-16.29% | 52.88B | |
+27.96% | 50.84B | |
-27.56% | 46.09B | |
+15.13% | 41.3B | |
+56.02% | 37.06B | |
-11.27% | 24.61B |
- Stock Market
- Equities
- MYRN Stock
- Company Myriad Group AG